• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剖宫产及产后时期丙泊酚的处置情况。

Disposition of propofol at caesarean section and in the postpartum period.

作者信息

Gin T, Yau G, Jong W, Tan P, Leung R K, Chan K

机构信息

Department of Anaesthesia & Intensive Care, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin.

出版信息

Br J Anaesth. 1991 Jul;67(1):49-53. doi: 10.1093/bja/67.1.49.

DOI:10.1093/bja/67.1.49
PMID:1859759
Abstract

We have compared the pharmacokinetics of a bolus dose of propofol 2 mg kg-1 in eight patients undergoing Caesarean section with those in eight postpartum patients undergoing sterilization by mini-laparotomy. The Caesarean section group had a total body clearance of (median) 31.5 (range 24.4-53.3) ml min-1 kg-1, apparent volume of distribution at steady state 5.10 (2.46-6.61) litre kg-1 and mean residence time 161 (52.3-251) min; values for the post-partum group were 33.8 (21.5-47.2) ml min-1 kg-1, 5.17 (3.47-8.09) litre kg-1 and 163 (92.3-238) min, respectively. The 95% confidence interval for the umbilical venous to maternal venous ratio of propofol at delivery was 0.62-0.86. Plasma protein binding studies showed there was less unbound propofol in maternal plasma (1.28-2.29%) compared with umbilical plasma (2.08-3.88%) (P less than 0.01). Neonatal concentrations of propofol were greater than maternal concentrations at 2 h and were in the range 0.05-0.11 micrograms ml-1 at 4 h.

摘要

我们比较了8例剖宫产患者静脉注射2mg/kg丙泊酚后的药代动力学参数,并与8例接受小切口绝育术的产后患者进行了对比。剖宫产组的总体清除率(中位数)为31.5(范围24.4 - 53.3)ml·min⁻¹·kg⁻¹,稳态分布容积为5.10(2.46 - 6.61)L·kg⁻¹,平均驻留时间为161(52.3 - 251)分钟;产后组的相应值分别为33.8(21.5 - 47.2)ml·min⁻¹·kg⁻¹、5.17(3.47 - 8.09)L·kg⁻¹和163(92.3 - 238)分钟。分娩时丙泊酚脐静脉与母体静脉浓度比的95%置信区间为0.62 - 0.86。血浆蛋白结合研究表明,母体血浆中未结合的丙泊酚较少(1.28 - 2.29%),而脐血浆中为2.08 - 3.88%(P<0.01)。丙泊酚在新生儿体内的浓度在2小时时高于母体,在4小时时为0.05 - 0.11μg/ml。

相似文献

1
Disposition of propofol at caesarean section and in the postpartum period.剖宫产及产后时期丙泊酚的处置情况。
Br J Anaesth. 1991 Jul;67(1):49-53. doi: 10.1093/bja/67.1.49.
2
Disposition of propofol infusions for caesarean section.剖宫产丙泊酚输注的处置
Can J Anaesth. 1991 Jan;38(1):31-6. doi: 10.1007/BF03009160.
3
Pharmacokinetics of propofol in women undergoing elective caesarean section.
Br J Anaesth. 1990 Feb;64(2):148-53. doi: 10.1093/bja/64.2.148.
4
Maternal and fetal levels of propofol at caesarean section.剖宫产时母体和胎儿体内丙泊酚的水平。
Anaesth Intensive Care. 1990 May;18(2):180-4. doi: 10.1177/0310057X9001800204.
5
Placental transfer and neonatal effects of propofol in caesarean section.剖宫产术中丙泊酚的胎盘转运及对新生儿的影响
J Clin Pharm Ther. 1998 Feb;23(1):19-23.
6
Propofol in combination with remifentanil for cesarean section: Placental transfer and effect on mothers and newborns at different induction to delivery intervals.丙泊酚联合瑞芬太尼用于剖宫产:不同诱导至分娩间隔下的胎盘转运及其对母亲和新生儿的影响
Taiwan J Obstet Gynecol. 2017 Aug;56(4):521-526. doi: 10.1016/j.tjog.2016.09.010.
7
[Concentrations of propofol in maternal and fetal blood during anesthesia for cesarean section].
Minerva Anestesiol. 1993 Sep;59(9):435-40.
8
Propofol in cesarean section. A pharmacokinetic and pharmacodynamic study.
Methods Find Exp Clin Pharmacol. 1990 Dec;12(10):707-11.
9
Intravenous propofol during cesarean section: placental transfer, concentrations in breast milk, and neonatal effects. A preliminary study.剖宫产术中静脉注射丙泊酚:胎盘转运、母乳中的浓度及对新生儿的影响。一项初步研究。
Anesthesiology. 1989 Dec;71(6):827-34. doi: 10.1097/00000542-198912000-00003.
10
[The pharmacokinetics of propofol used in cesarean section; a preliminary study in the newborn infant].剖宫产术中丙泊酚的药代动力学;新生儿初步研究
Cah Anesthesiol. 1989 Jan-Feb;37(1):33-7.

引用本文的文献

1
In vitro changes in the proportion of protein-unbound-free propofol induced by valproate.缬草酸盐诱导的游离丙泊酚蛋白结合率的体外变化。
J Anesth. 2018 Oct;32(5):688-693. doi: 10.1007/s00540-018-2540-6. Epub 2018 Jul 30.
2
Clinical Pharmacokinetics and Pharmacodynamics of Propofol.丙泊酚的临床药代动力学和药效学。
Clin Pharmacokinet. 2018 Dec;57(12):1539-1558. doi: 10.1007/s40262-018-0672-3.
3
Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.生理药代动力学模型在孕妇肾清除药物中的应用。
Clin Pharmacokinet. 2017 Dec;56(12):1525-1541. doi: 10.1007/s40262-017-0538-0.
4
Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review.妊娠相关的药代动力学变化:一项系统评价。
PLoS Med. 2016 Nov 1;13(11):e1002160. doi: 10.1371/journal.pmed.1002160. eCollection 2016 Nov.
5
Propofol Pharmacokinetics and Estimation of Fetal Propofol Exposure during Mid-Gestational Fetal Surgery: A Maternal-Fetal Sheep Model.丙泊酚的药代动力学及孕中期胎儿手术期间胎儿丙泊酚暴露量的估算:母胎绵羊模型
PLoS One. 2016 Jan 11;11(1):e0146563. doi: 10.1371/journal.pone.0146563. eCollection 2016.
6
The pharmacology of cyclopropyl-methoxycarbonyl metomidate: a comparison with propofol.环丙基甲氧羰基美托咪定的药理学:与丙泊酚的比较。
Anesth Analg. 2014 Mar;118(3):563-7. doi: 10.1213/ANE.0000000000000069.
7
Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics.丙泊酚与血液成分的结合:对药代动力学和药效学的影响。
Br J Clin Pharmacol. 1999 Jan;47(1):35-42. doi: 10.1046/j.1365-2125.1999.00860.x.
8
Propofol. An update of its use in anaesthesia and conscious sedation.丙泊酚。其在麻醉和清醒镇静中应用的最新情况。
Drugs. 1995 Sep;50(3):513-59. doi: 10.2165/00003495-199550030-00008.
9
Pharmacokinetic optimisation of general anaesthesia in pregnancy.孕期全身麻醉的药代动力学优化
Clin Pharmacokinet. 1993 Jul;25(1):59-70. doi: 10.2165/00003088-199325010-00004.